<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-id journal-id-type="iso-abbrev">Lipids Health Dis</journal-id><journal-title-group><journal-title>Lipids in Health and Disease</journal-title></journal-title-group><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22584034</article-id><article-id pub-id-type="pmc">3475063</article-id><article-id pub-id-type="publisher-id">1476-511X-11-52</article-id><article-id pub-id-type="doi">10.1186/1476-511X-11-52</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title>Supplementation of highly concentrated &#x003b2;-cryptoxanthin in a satsuma mandarin beverage improves adipocytokine profiles in obese Japanese women</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Iwamoto</surname><given-names>Masako</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>iwamoto@nakamura-u.ac.jp</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Imai</surname><given-names>Katsumi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>katsumi@nakamura-u.ac.jp</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Ohta</surname><given-names>Hideaki</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hohta@nakamura-u.ac.jp</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Shirouchi</surname><given-names>Bungo</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>bungos@agr.kyushu-u.ac.jp</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Sato</surname><given-names>Masao</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>masaos@agr.kyushu-u.ac.jp</email></contrib></contrib-group><aff id="I1"><label>1</label>Graduate School of Health and Nutrition Sciences, Nakamura Gakuen University, 5-7-1 Befu, Jounan-Ku, Fukuoka 814-0198, Japan</aff><aff id="I2"><label>2</label>Laboratory of Nutrition Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan</aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>14</day><month>5</month><year>2012</year></pub-date><volume>11</volume><fpage>52</fpage><lpage>52</lpage><history><date date-type="received"><day>20</day><month>4</month><year>2012</year></date><date date-type="accepted"><day>4</day><month>5</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2012 Iwamoto et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Iwamoto et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.lipidworld.com/content/11/1/52"/><abstract><sec><title>Background</title><p>Serum &#x003b2;-cryptoxanthin levels are lower in overweight subjects than in normal subjects. Abnormalities of adipocytokine profiles in obesity subjects have been reported. There are several reports that serum &#x003b2;-cryptoxanthin levels in them were relatively lower than normal subjects.</p></sec><sec><title>Objective</title><p>We hypothesize that supplementation of highly concentrated &#x003b2;-cryptoxanthin improves serum adipocytokine profiles in obese subjects. This study tested the association between &#x003b2;-cryptoxanthin intake and serum adipocytokine levels.</p></sec><sec><title>Methods</title><p>An intervention study consisted of a 3-week long before-and-after controlled trial, where &#x003b2;-cryptoxanthin (4.7&#x02009;mg/day) was given to 17 moderately obese postmenopausal women.</p></sec><sec><title>Results</title><p>The results indicated no significant changes in body weight or body mass index (BMI). Serum &#x003b2;-cryptoxanthin levels increased significantly by 4-fold. Serum high molecular weight (HMW)-adiponectin levels increased significantly, while serum plasminogen activator inhibitor (PAI)-1 levels decreased.</p></sec><sec><title>Conclusions</title><p>We concluded that increasing the intake of &#x003b2;-cryptoxanthin to approximately 4&#x02009;mg per day for 3&#x02009;weeks may have beneficial effects on the serum adipocytokine status and consequently alleviate progression of metabolic syndrome.</p></sec></abstract><kwd-group><kwd>&#x003b2;-cryptoxanthin supplementation</kwd><kwd>Serum HMW-adiponectin</kwd><kwd>Serum PAI-1</kwd><kwd>Intervention study</kwd><kwd>Satsuma mandarin</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Serum &#x003b2;-cryptoxanthin levels (Figure <xref ref-type="fig" rid="F1">1</xref>) are lower in overweight subjects than in normal subjects, irrespective of dietary intake [<xref ref-type="bibr" rid="B1">1</xref>]. In a case-controlled study, which was part of a larger survey of 2895 subjects with body mass indexes (BMI) greater than 25, serum &#x003b2;-cryptoxanthin levels were found to be lower than in subjects with BMIs lower than 25 [<xref ref-type="bibr" rid="B2">2</xref>]. Adipose tissue store excess energy in the form of fat and secretes physiologically active substances known as adipocytokines [<xref ref-type="bibr" rid="B3">3</xref>]. Among these compounds, adiponectin is the most abundant adipose-specific protein. Plasma adiponectin levels are negatively correlated with BMI in men and women [<xref ref-type="bibr" rid="B4">4</xref>]. Growing evidence suggests that high-molecular weight (HMW)-adiponectin is the most physiologically active form present in metabolic disorders [<xref ref-type="bibr" rid="B5">5</xref>]. Plasminogen activator inhibitor-1 (PAI-1) is a non-specific adipocytokine and its levels are positively correlated with the area of visceral fat determined by computed tomography (CT) scan of obese and non-obese subjects [<xref ref-type="bibr" rid="B6">6</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>The chemical structure of &#x003b2;-cryptoxanthin.</p></caption><graphic xlink:href="1476-511X-11-52-1"/></fig><p>Serum &#x003b2;-cryptoxanthin levels have been reported in subjects with metabolic syndrome [<xref ref-type="bibr" rid="B1">1</xref>], but no intervention studies have provided dietary &#x003b2;-cryptoxanthin to subjects. We hypothesize that supplementation of highly concentrated &#x003b2;-cryptoxanthin improves serum adipocytokine profiles in obese subjects. This study aimed to assess the degree of adiposity and serum adipocytokine levels in middle-aged postmenopausal women with a BMI of 25&#x02013;30, who had been administered a beverage containing high concentrations of &#x003b2;-cryptoxanthin for 3&#x02009;weeks.</p></sec><sec sec-type="materials|methods"><title>Methods and materials</title><sec><title>Subjects</title><p>Seventeen postmenopausal obese women participated in this study. Obesity was defined as a body mass index (BMI) greater than 25&#x02009;kg/m<sup>2</sup>, according to the Japan Society for the Study of Obesity. Criteria for participation in this study included no past history of diabetes mellitus, no use of prescribed medicine, and no history of smoking. This study was approved by the Nakamura Gakuen University Committee (No. 05&#x02013;009), in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.</p><p>The daily nutrient intake of the subjects was monitored for 3&#x02009;days before the start and 3&#x02009;days after the study by means of dietary records. Subjects were instructed to continue with their usual diets, but were prohibited from the intake of citrus fruits, persimmon, and the juices of either fruits during the period of the investigation. The nutrient intake was calculated using Excel Eiyou-kun ver. 3 (Kenpaku-sha, Tokyo, Japan). The intervention study was a 3-week long before-and-after controlled trial, where 200&#x02009;ml of a beverage containing &#x003b2;-cryptoxanthin (1.56&#x02009;mg/serving and 4.7&#x02009;mg/day) was provided to the subjects. Other ingredients of the beverage which we determined were as follows, energy (27&#x02009;kcal/serving), water (183.4&#x02009;g/serving), protein (0.6&#x02009;g/serving), lipids (&#x0003c; 0.2&#x02009;g/serving), ash (&#x0003c; 0.2&#x02009;g/serving), total carbohydrate (6.1&#x02009;g/serving), sugars (3.78&#x02009;g/serving), dietary fiber (1.1&#x02009;g/serving), potassium (71.6&#x02009;mg/serving), calcium (12.0&#x02009;mg/serving), sodium (0.8&#x02009;mg/serving), magnesium (5.7&#x02009;mg/serving), vitamin C (49.10&#x02009;mg/serving), &#x003b2;-carotene (0.19&#x02009;mg/serving). The beverage was prepared from residues generated by the process used in the manufacture of satsuma mandarin juice. The residues contained higher concentrations of &#x003b2;-cryptoxanthin than the manufactured juice. The beverage was prepared by resuspending the residues in water, and &#x003b2;-cryptoxanthin levels in the beverage were identical in each serving.</p></sec><sec><title>Blood sampling and biochemical measurements</title><p>Blood samples were assayed for total cholesterol, triglyceride, high-density lipoprotein (HDL) cholesterol, glucose, HMW-adiponectin, leptin, total PAI-1, and insulin in a commercial laboratory (SRL, Fukuoka, Japan). Plasma carotenoid levels were measured in a commercial laboratory (BIKEN, Kyoto, Japan). Plasma carotenoids, including, &#x003b1; -carotene, &#x003b2;-carotene, &#x003b2;-cryptoxanthin, lycopene, and lutein-zeaxanthin, were extracted and concentrated using standard methods. These compounds were then quantified by reversed-phase high-performance liquid chromatography (HPLC).</p></sec><sec><title>Statistical analyses</title><p>All values are expressed as mean&#x02009;&#x000b1;&#x02009;SE. The statistical difference was determined using a two-tailed paired <italic>t</italic>-test. <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered significant.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The baseline characteristics of the subjects at the beginning of the investigation are shown in Table <xref ref-type="table" rid="T1">1</xref>. Postmenopausal women were selected on the basis of BMI. The highest BMI was 32.1 and the lowest was 23.1. There were no differences in body weight or BMI after the treatment. Serum triglyceride levels at the end of the study tended to decrease (<italic>P</italic>&#x02009;=&#x02009;0.057). There were no significant differences in total serum low-density lipoprotein (LDL) and HDL cholesterol levels. Subjects had blood pressure measurements in the normal range at the beginning of the study, and this was also the case for the serum parameters (Table <xref ref-type="table" rid="T2">2</xref>). After drinking the beverage containing &#x003b2;-cryptoxanthin for 3&#x02009;weeks, serum &#x003b2;-cryptoxanthin levels significantly increased 4-fold. The results show that serum HMW-adiponectin levels at the end of the study were significantly higher compared with the initial period. Serum total PAI-1 levels at the end of the study tended to be lower (<italic>P</italic>&#x02009;=&#x02009;0.052). The levels of other carotenoids, such as lycopene, &#x003b1;-carotene, &#x003b2;-carotene, and zeaxanthin, were not significantly different after the treatment.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Comparison of clinical data and daily intake of nutrients before and after 3-weeks intake of a &#x003b2;-cryptoxanthin beverage (n&#x02009;=&#x02009;17)</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Characteristics</bold></th><th align="center"><bold>Before</bold></th><th align="center"><bold>After</bold></th><th align="center"><bold>Change</bold><sup><bold>1)</bold></sup></th><th align="center"><bold>&#x02009;<italic>P</italic>&#x02009;</bold><bold>-value</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Age (years)<hr/></td><td align="center" valign="bottom">55&#x02009;&#x000b1;&#x02009;1.7<hr/></td><td align="center" valign="bottom">55&#x02009;&#x000b1;&#x02009;1.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Height (cm)<hr/></td><td align="center" valign="bottom">154.5&#x02009;&#x000b1;&#x02009;0.9<hr/></td><td align="center" valign="bottom">154.5&#x02009;&#x000b1;&#x02009;0.9<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Body weight (kg)<hr/></td><td align="center" valign="bottom">64.9&#x02009;&#x000b1;&#x02009;1.7<hr/></td><td align="center" valign="bottom">64.8&#x02009;&#x000b1;&#x02009;1.7<hr/></td><td align="center" valign="bottom">&#x02212;0.1<hr/></td><td align="center" valign="bottom">0.473<hr/></td></tr><tr><td align="left" valign="bottom">BMI (kg/cm<sup>2</sup>)<hr/></td><td align="center" valign="bottom">27.1&#x02009;&#x000b1;&#x02009;0.6<hr/></td><td align="center" valign="bottom">27.1&#x02009;&#x000b1;&#x02009;0.6<hr/></td><td align="center" valign="bottom">0<hr/></td><td align="center" valign="bottom">0.722<hr/></td></tr><tr><td align="left" valign="bottom">Blood pressure<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">SBP (mmHg)<hr/></td><td align="center" valign="bottom">134&#x02009;&#x000b1;&#x02009;4.6<hr/></td><td align="center" valign="bottom">128&#x02009;&#x000b1;&#x02009;3.7<hr/></td><td align="center" valign="bottom">&#x02212;6<hr/></td><td align="center" valign="bottom">0.052<hr/></td></tr><tr><td align="left" valign="bottom">DBP (mmHg)<hr/></td><td align="center" valign="bottom">80&#x02009;&#x000b1;&#x02009;2.2<hr/></td><td align="center" valign="bottom">79&#x02009;&#x000b1;&#x02009;2.1<hr/></td><td align="center" valign="bottom">&#x02212;1<hr/></td><td align="center" valign="bottom">0.366<hr/></td></tr><tr><td align="left" valign="bottom">Dietary intake per day<sup>2)</sup><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Energy (kcal)<hr/></td><td align="center" valign="bottom">1659&#x02009;&#x000b1;&#x02009;101<hr/></td><td align="center" valign="bottom">1676&#x02009;&#x000b1;&#x02009;96<hr/></td><td align="center" valign="bottom">17<hr/></td><td align="center" valign="bottom">0.805<hr/></td></tr><tr><td align="left" valign="bottom">Protein (g)<hr/></td><td align="center" valign="bottom">69.3&#x02009;&#x000b1;&#x02009;3.7<hr/></td><td align="center" valign="bottom">67.5&#x02009;&#x000b1;&#x02009;3.5<hr/></td><td align="center" valign="bottom">&#x02212;1.8<hr/></td><td align="center" valign="bottom">0.597<hr/></td></tr><tr><td align="left" valign="bottom">Fat (g)<hr/></td><td align="center" valign="bottom">51.4&#x02009;&#x000b1;&#x02009;3.8<hr/></td><td align="center" valign="bottom">50.9&#x02009;&#x000b1;&#x02009;3.6<hr/></td><td align="center" valign="bottom">&#x02212;0.4<hr/></td><td align="center" valign="bottom">0.943<hr/></td></tr><tr><td align="left" valign="bottom">Carbohydrate (g)<hr/></td><td align="center" valign="bottom">225.2&#x02009;&#x000b1;&#x02009;15.4<hr/></td><td align="center" valign="bottom">223.9&#x02009;&#x000b1;&#x02009;15.6<hr/></td><td align="center" valign="bottom">&#x02212;1.4<hr/></td><td align="center" valign="bottom">0.916<hr/></td></tr><tr><td align="left" valign="bottom">Dietary fibre (g)<hr/></td><td align="center" valign="bottom">16.5&#x02009;&#x000b1;&#x02009;1.0<hr/></td><td align="center" valign="bottom">20.1&#x02009;&#x000b1;&#x02009;1.6<hr/></td><td align="center" valign="bottom">3.6<hr/></td><td align="center" valign="bottom">0.035<hr/></td></tr><tr><td align="left" valign="bottom">&#x003b2;-Cryptoxanthin (mg)<hr/></td><td align="center" valign="bottom">723&#x02009;&#x000b1;&#x02009;237<hr/></td><td align="center" valign="bottom">4719&#x02009;&#x000b1;&#x02009;6<hr/></td><td align="center" valign="bottom">3996<hr/></td><td align="center" valign="bottom">0.000<hr/></td></tr><tr><td align="left">Vitamin C (mg)</td><td align="center">133&#x02009;&#x000b1;&#x02009;15</td><td align="center">231&#x02009;&#x000b1;&#x02009;7</td><td align="center">98</td><td align="center">0.000</td></tr></tbody></table><table-wrap-foot><p>Data show means&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;S.E.</p><p>Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p><sup>1)</sup> Change implies subtraction of &#x02018;before&#x02019; data from &#x02018;after&#x02019; data.</p><p><sup>2)</sup> Included beverage.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Comparison of FBG, serum lipid, adipocytokine, and carotenoid levels before and after 3-weeks intake of a &#x003b2;-cryptoxanthin beverage (n&#x02009;=&#x02009;17)</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Characteristics</bold></th><th align="center"><bold>Before</bold></th><th align="center"><bold>After</bold></th><th align="center"><bold>Change*</bold></th><th align="center"><bold>&#x02009;<italic>P</italic>&#x02009;</bold><bold>-value</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">FBG (mg/dl)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">101&#x02009;&#x000b1;&#x02009;3<hr/></td><td align="char" valign="bottom" char="&#x000b1;">101&#x02009;&#x000b1;&#x02009;2<hr/></td><td align="char" valign="bottom" char=".">1<hr/></td><td align="char" valign="bottom" char=".">0.749<hr/></td></tr><tr><td align="left" valign="bottom">Total-cholesterol (mg/dl)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">216&#x02009;&#x000b1;&#x02009;6<hr/></td><td align="char" valign="bottom" char="&#x000b1;">217&#x02009;&#x000b1;&#x02009;6<hr/></td><td align="char" valign="bottom" char=".">1<hr/></td><td align="char" valign="bottom" char=".">0.827<hr/></td></tr><tr><td align="left" valign="bottom">LDL-cholesterol (mg/dl)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">135&#x02009;&#x000b1;&#x02009;6<hr/></td><td align="char" valign="bottom" char="&#x000b1;">136&#x02009;&#x000b1;&#x02009;6<hr/></td><td align="char" valign="bottom" char=".">0<hr/></td><td align="char" valign="bottom" char=".">0.949<hr/></td></tr><tr><td align="left" valign="bottom">HDL-cholesterol (mg/dl)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">64&#x02009;&#x000b1;&#x02009;3<hr/></td><td align="char" valign="bottom" char="&#x000b1;">64&#x02009;&#x000b1;&#x02009;3<hr/></td><td align="char" valign="bottom" char=".">0<hr/></td><td align="char" valign="bottom" char=".">0.803<hr/></td></tr><tr><td align="left" valign="bottom">Triglyceride (mg/dl)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">116&#x02009;&#x000b1;&#x02009;14<hr/></td><td align="char" valign="bottom" char="&#x000b1;">100&#x02009;&#x000b1;&#x02009;12<hr/></td><td align="char" valign="bottom" char=".">&#x02212;16<hr/></td><td align="char" valign="bottom" char=".">0.057<hr/></td></tr><tr><td align="left" valign="bottom">Leptin (mg/dl)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">15.7&#x02009;&#x000b1;&#x02009;1.8<hr/></td><td align="char" valign="bottom" char="&#x000b1;">15.5&#x02009;&#x000b1;&#x02009;2.0<hr/></td><td align="char" valign="bottom" char=".">&#x02212;0.2<hr/></td><td align="char" valign="bottom" char=".">0.853<hr/></td></tr><tr><td align="left" valign="bottom">HMW-Adiponectin (mg/ml)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">9.8&#x02009;&#x000b1;&#x02009;1.2<hr/></td><td align="char" valign="bottom" char="&#x000b1;">11.1&#x02009;&#x000b1;&#x02009;1.1<hr/></td><td align="char" valign="bottom" char=".">1.3<hr/></td><td align="char" valign="bottom" char=".">0.009<hr/></td></tr><tr><td align="left" valign="bottom">Total PAI-1 (ng/ml)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">32&#x02009;&#x000b1;&#x02009;3<hr/></td><td align="char" valign="bottom" char="&#x000b1;">28&#x02009;&#x000b1;&#x02009;3<hr/></td><td align="char" valign="bottom" char=".">&#x02212;4<hr/></td><td align="char" valign="bottom" char=".">0.052<hr/></td></tr><tr><td align="left" valign="bottom">&#x003b2;-cryptoxanthin (mg/ml)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">0.28&#x02009;&#x000b1;&#x02009;0.04<hr/></td><td align="char" valign="bottom" char="&#x000b1;">1.15&#x02009;&#x000b1;&#x02009;0.08<hr/></td><td align="char" valign="bottom" char=".">0.86<hr/></td><td align="char" valign="bottom" char=".">0.000<hr/></td></tr><tr><td align="left" valign="bottom">Lycopene (mg/ml)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">0.18&#x02009;&#x000b1;&#x02009;0.02<hr/></td><td align="char" valign="bottom" char="&#x000b1;">0.18&#x02009;&#x000b1;&#x02009;0.01<hr/></td><td align="char" valign="bottom" char=".">0.00<hr/></td><td align="char" valign="bottom" char=".">0.741<hr/></td></tr><tr><td align="left" valign="bottom">&#x003b1;-carotene (mg/ml)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">0.09&#x02009;&#x000b1;&#x02009;0.02<hr/></td><td align="char" valign="bottom" char="&#x000b1;">0.09&#x02009;&#x000b1;&#x02009;0.01<hr/></td><td align="char" valign="bottom" char=".">0.00<hr/></td><td align="char" valign="bottom" char=".">0.795<hr/></td></tr><tr><td align="left" valign="bottom">&#x003b2;-carotene (mg/ml)<hr/></td><td align="char" valign="bottom" char="&#x000b1;">0.37&#x02009;&#x000b1;&#x02009;0.04<hr/></td><td align="char" valign="bottom" char="&#x000b1;">0.38&#x02009;&#x000b1;&#x02009;0.03<hr/></td><td align="char" valign="bottom" char=".">0.00<hr/></td><td align="char" valign="bottom" char=".">0.793<hr/></td></tr><tr><td align="left">Zeaxanthin (mg/ml)</td><td align="char" char="&#x000b1;">0.07&#x02009;&#x000b1;&#x02009;0.01</td><td align="char" char="&#x000b1;">0.07&#x02009;&#x000b1;&#x02009;0.01</td><td align="char" char=".">0.00</td><td align="char" char=".">0.901</td></tr></tbody></table><table-wrap-foot><p>Data show means&#x02009;&#x000b1;&#x02009;S. E.</p><p>Abbreviations: FBG, fasting blood glucose; HMW, high molecular weight; PAI-1, plasminogen activator inhibitor-1* Change implies subtraction of &#x02018;before&#x02019; data from &#x02018;after&#x02019; data.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>This study investigated the potential effects of &#x003b2;-cryptoxanthin supplementation on obesity. There were no significant effects on body weight and BMI after the 3-week treatment. However, &#x003b2;-cryptoxanthin supplementation improved the adipocytokine status, as indicated by increased serum HMW-adiponectin levels and decreased PAI-1 levels.</p><p>A previous study [<xref ref-type="bibr" rid="B7">7</xref>] reported that a Mediterranean diet leads to increased serum adiponectin levels in metabolic syndrome subjects. In a short-term study, Shimada <italic>et al.</italic>[<xref ref-type="bibr" rid="B8">8</xref>] reported that supplementation of the diet of 17 elderly men with normal BMI values with Oolong tea (1,000&#x02009;ml/day) for 4&#x02009;weeks increased the plasma adiponectin levels, but without any decrease in body weight. Sluijs <italic>et al.</italic>[<xref ref-type="bibr" rid="B9">9</xref>] reported that higher intake of dietary carotenoid, particularly &#x003b2;-cryptoxanthin and lycopene, was associated with a reduced prevalence of metabolic syndrome in middle-aged elderly men. Daily &#x003b2;-cryptoxanthin intakes in the Sluijs <italic>et al.</italic>[<xref ref-type="bibr" rid="B9">9</xref>] study were 1/37<sup>th</sup> of that found in the current study. However, the dietary &#x003b2;-carotene and lycopene intake in the Sluijs <italic>et al.</italic>[<xref ref-type="bibr" rid="B9">9</xref>] study was almost the same as that found in the current study. Thus, daily consumption of milligram-scale carotenoids, including, &#x003b2;-carotene, lycopene, and &#x003b2;-cryptoxanthin, might alleviate metabolic syndrome.</p><p>Jones <italic>et al</italic>. [<xref ref-type="bibr" rid="B10">10</xref>] reported a correlation between serum PAI-1 levels and carotenoid bioavailability in an intervention study, where fish-oil esters of plant sterols were added to the diets of moderately overweight and hypercholesterolemic subjects over a period of 4&#x02009;weeks. Compared with supplementation with safflower oil esters, supplementation with fish-oil esters of plant sterols significantly elevated the serum levels of retinol and &#x003b2;-carotenes and decreased serum PAI-1 levels. Thus, an increased in serum carotenoid levels might result in a decrease of serum PAI-1 levels. In this study, serum &#x003b2;-cryptoxanthin levels increased, whereas PAI-1 levels decreased.</p><p>In conclusion, increasing &#x003b2;-cryptoxanthin intake to approximately 4&#x02009;mg per day for 3&#x02009;weeks could have beneficial effects on serum adipocytokine status, and subsequently alleviate progression of metabolic syndrome. Further case&#x02013;control study in larger scale may be needed to prove sound relationships between &#x003b2;-cryptoxanthin intake and the risk of development of metabolic syndrome.</p></sec><sec><title>Abbreviations</title><p>HMW-adiponectin: High molecular weight adiponectin; PAI-1: Plasminogen activator inhibitor; BMI: Body mass index; DBP: Diastolic blood pressure; FBG: Fasting blood glucose; SBP: Systolic blood pressure.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>MI conceived the study, participated in the design of the study, acquired data, performed statistical analysis and drafted the manuscript. KI and HO carried out the survey and organized the data. BS and MS participated in the design on the study and helped conducting the study. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This work was in part supported by a grant from the Research and Development Program for New Bio-industry initiatives of the Bio-oriented Technology Research Advancement Institution, Japan.</p></sec></body><back><sec><title>Acknowledgments</title><p>The present study was supported by grants from the National Agriculture and Bio-oriented Research Organization (Bio-oriented Technology Research Advancement Institution), Japan.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Kabagambe</surname><given-names>EK</given-names></name><name><surname>Furtado</surname><given-names>J</given-names></name><name><surname>Baylin</surname><given-names>A</given-names></name><name><surname>Campos</surname><given-names>H</given-names></name><article-title>Some dietary and adipose tissue carotenoids are associated with the risk of nonfatal acute myocardial infarction in Costa Rica</article-title><source>J Nutr</source><year>2005</year><volume>135</volume><fpage>1763</fpage><lpage>1769</lpage><pub-id pub-id-type="pmid">15987862</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>LF</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names></name><name><surname>Gross</surname><given-names>MD</given-names></name><name><surname>Schreiner</surname><given-names>PJ</given-names></name><name><surname>Williams</surname><given-names>OD</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><article-title>Longitudinal associations between body mass index and serum carotenoids: the CARDIA study</article-title><source>British Journal of Nutrition</source><year>2006</year><volume>95</volume><fpage>358</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1079/BJN20051638</pub-id><pub-id pub-id-type="pmid">16469154</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><name><surname>Funahashi</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><article-title>Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances</article-title><source>Ann NY Acad Sci</source><year>1999</year><volume>892</volume><fpage>146</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1999.tb07793.x</pub-id><pub-id pub-id-type="pmid">10842660</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Arita</surname><given-names>Y</given-names></name><name><surname>Kihara</surname><given-names>S</given-names></name><name><surname>Ouchi</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Miyagawa</surname><given-names>J</given-names></name><name><surname>Hotta</surname><given-names>K</given-names></name><name><surname>Shimomura</surname><given-names>I</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Miyaoka</surname><given-names>K</given-names></name><name><surname>Kuriyama</surname><given-names>H</given-names></name><name><surname>Nishida</surname><given-names>M</given-names></name><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name><name><surname>Matsubara</surname><given-names>K</given-names></name><name><surname>Muraguchi</surname><given-names>M</given-names></name><name><surname>Ohmoto</surname><given-names>Y</given-names></name><name><surname>Funahashi</surname><given-names>T</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><article-title>Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity</article-title><source>Biochem Biophys Res Commun</source><year>1999</year><volume>257</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1999.0255</pub-id><pub-id pub-id-type="pmid">10092513</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Lara-Castro</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>N</given-names></name><name><surname>Wallace</surname><given-names>P</given-names></name><name><surname>Klein</surname><given-names>RL</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name><article-title>Adiponectin multimeric complexes and the metabolic syndrome trait cluster</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>249</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.2337/diabetes.55.01.06.db05-1105</pub-id><pub-id pub-id-type="pmid">16380500</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Shimomura</surname><given-names>I</given-names></name><name><surname>Funahashi</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Kotani</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name><name><surname>Fukuda</surname><given-names>Y</given-names></name><name><surname>Takemura</surname><given-names>K</given-names></name><name><surname>Tokunaga</surname><given-names>K</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><article-title>Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><fpage>800</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1038/nm0796-800</pub-id><pub-id pub-id-type="pmid">8673927</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Mantzoros</surname><given-names>CS</given-names></name><name><surname>Williams</surname><given-names>CJ</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><article-title>Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>84</volume><fpage>328</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">16895879</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Shimada</surname><given-names>K</given-names></name><name><surname>Kawarabayashi</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>A</given-names></name><name><surname>Fukuda</surname><given-names>D</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Yoshiyama</surname><given-names>M</given-names></name><name><surname>Takeuchi</surname><given-names>K</given-names></name><name><surname>Sawaki</surname><given-names>T</given-names></name><name><surname>Hosoda</surname><given-names>K</given-names></name><name><surname>Yoshikawa</surname><given-names>J</given-names></name><article-title>Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease</article-title><source>Diabetes Res Clin Pract</source><year>2004</year><volume>65</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2004.01.003</pub-id><pub-id pub-id-type="pmid">15331202</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Sluijs</surname><given-names>I</given-names></name><name><surname>Beulens</surname><given-names>JW</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>van der Schouw</surname><given-names>YH</given-names></name><article-title>Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men</article-title><source>J Nutr</source><year>2009</year><volume>139</volume><fpage>987</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.3945/jn.108.101451</pub-id><pub-id pub-id-type="pmid">19321578</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>PJ</given-names></name><name><surname>Demonty</surname><given-names>I</given-names></name><name><surname>Chan</surname><given-names>YM</given-names></name><name><surname>Herzog</surname><given-names>Y</given-names></name><name><surname>Pelled</surname><given-names>D</given-names></name><article-title>Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects</article-title><source>Lipids Health Dis</source><year>2007</year><volume>25</volume><fpage>6</fpage><lpage>28</lpage></mixed-citation></ref></ref-list></back></article>